According to the National Center for Policy Analysis, industry consolidation and diminishing competition are causing the price of many generic drugs to rise. Experts say this is because only a few manufacturers are producing certain drugs and a number of older generics are being phased out. At the same time, governments are trying to protect consumers by placing more and more restrictions on mail-order pharmacies and working to ban some pharmacy networks. To address this combination of less competition and more regulation, many recommend avoiding more regulations and faster application processing by the FDA.
Leave A Comment